List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Drug Repositioning Market Size Analysis from 2022 to 2027
1.5.1 Global Drug Repositioning Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Drug Repositioning Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Drug Repositioning Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Drug Repositioning Industry Impact
Chapter 2 Global Drug Repositioning Competition by Types, Applications, and Top Regions and Countries
2.1 Global Drug Repositioning (Volume and Value) by Type
2.1.1 Global Drug Repositioning Consumption and Market Share by Type (2016-2021)
2.1.2 Global Drug Repositioning Revenue and Market Share by Type (2016-2021)
2.2 Global Drug Repositioning (Volume and Value) by Application
2.2.1 Global Drug Repositioning Consumption and Market Share by Application (2016-2021)
2.2.2 Global Drug Repositioning Revenue and Market Share by Application (2016-2021)
2.3 Global Drug Repositioning (Volume and Value) by Regions
2.3.1 Global Drug Repositioning Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Drug Repositioning Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Drug Repositioning Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Drug Repositioning Consumption by Regions (2016-2021)
4.2 North America Drug Repositioning Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Drug Repositioning Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Drug Repositioning Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Drug Repositioning Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Drug Repositioning Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Drug Repositioning Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Drug Repositioning Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Drug Repositioning Sales, Consumption, Export, Import (2016-2021)
4.10 South America Drug Repositioning Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Drug Repositioning Market Analysis
5.1 North America Drug Repositioning Consumption and Value Analysis
5.1.1 North America Drug Repositioning Market Under COVID-19
5.2 North America Drug Repositioning Consumption Volume by Types
5.3 North America Drug Repositioning Consumption Structure by Application
5.4 North America Drug Repositioning Consumption by Top Countries
5.4.1 United States Drug Repositioning Consumption Volume from 2016 to 2021
5.4.2 Canada Drug Repositioning Consumption Volume from 2016 to 2021
5.4.3 Mexico Drug Repositioning Consumption Volume from 2016 to 2021
Chapter 6 East Asia Drug Repositioning Market Analysis
6.1 East Asia Drug Repositioning Consumption and Value Analysis
6.1.1 East Asia Drug Repositioning Market Under COVID-19
6.2 East Asia Drug Repositioning Consumption Volume by Types
6.3 East Asia Drug Repositioning Consumption Structure by Application
6.4 East Asia Drug Repositioning Consumption by Top Countries
6.4.1 China Drug Repositioning Consumption Volume from 2016 to 2021
6.4.2 Japan Drug Repositioning Consumption Volume from 2016 to 2021
6.4.3 South Korea Drug Repositioning Consumption Volume from 2016 to 2021
Chapter 7 Europe Drug Repositioning Market Analysis
7.1 Europe Drug Repositioning Consumption and Value Analysis
7.1.1 Europe Drug Repositioning Market Under COVID-19
7.2 Europe Drug Repositioning Consumption Volume by Types
7.3 Europe Drug Repositioning Consumption Structure by Application
7.4 Europe Drug Repositioning Consumption by Top Countries
7.4.1 Germany Drug Repositioning Consumption Volume from 2016 to 2021
7.4.2 UK Drug Repositioning Consumption Volume from 2016 to 2021
7.4.3 France Drug Repositioning Consumption Volume from 2016 to 2021
7.4.4 Italy Drug Repositioning Consumption Volume from 2016 to 2021
7.4.5 Russia Drug Repositioning Consumption Volume from 2016 to 2021
7.4.6 Spain Drug Repositioning Consumption Volume from 2016 to 2021
7.4.7 Netherlands Drug Repositioning Consumption Volume from 2016 to 2021
7.4.8 Switzerland Drug Repositioning Consumption Volume from 2016 to 2021
7.4.9 Poland Drug Repositioning Consumption Volume from 2016 to 2021
Chapter 8 South Asia Drug Repositioning Market Analysis
8.1 South Asia Drug Repositioning Consumption and Value Analysis
8.1.1 South Asia Drug Repositioning Market Under COVID-19
8.2 South Asia Drug Repositioning Consumption Volume by Types
8.3 South Asia Drug Repositioning Consumption Structure by Application
8.4 South Asia Drug Repositioning Consumption by Top Countries
8.4.1 India Drug Repositioning Consumption Volume from 2016 to 2021
8.4.2 Pakistan Drug Repositioning Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Drug Repositioning Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Drug Repositioning Market Analysis
9.1 Southeast Asia Drug Repositioning Consumption and Value Analysis
9.1.1 Southeast Asia Drug Repositioning Market Under COVID-19
9.2 Southeast Asia Drug Repositioning Consumption Volume by Types
9.3 Southeast Asia Drug Repositioning Consumption Structure by Application
9.4 Southeast Asia Drug Repositioning Consumption by Top Countries
9.4.1 Indonesia Drug Repositioning Consumption Volume from 2016 to 2021
9.4.2 Thailand Drug Repositioning Consumption Volume from 2016 to 2021
9.4.3 Singapore Drug Repositioning Consumption Volume from 2016 to 2021
9.4.4 Malaysia Drug Repositioning Consumption Volume from 2016 to 2021
9.4.5 Philippines Drug Repositioning Consumption Volume from 2016 to 2021
9.4.6 Vietnam Drug Repositioning Consumption Volume from 2016 to 2021
9.4.7 Myanmar Drug Repositioning Consumption Volume from 2016 to 2021
Chapter 10 Middle East Drug Repositioning Market Analysis
10.1 Middle East Drug Repositioning Consumption and Value Analysis
10.1.1 Middle East Drug Repositioning Market Under COVID-19
10.2 Middle East Drug Repositioning Consumption Volume by Types
10.3 Middle East Drug Repositioning Consumption Structure by Application
10.4 Middle East Drug Repositioning Consumption by Top Countries
10.4.1 Turkey Drug Repositioning Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Drug Repositioning Consumption Volume from 2016 to 2021
10.4.3 Iran Drug Repositioning Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Drug Repositioning Consumption Volume from 2016 to 2021
10.4.5 Israel Drug Repositioning Consumption Volume from 2016 to 2021
10.4.6 Iraq Drug Repositioning Consumption Volume from 2016 to 2021
10.4.7 Qatar Drug Repositioning Consumption Volume from 2016 to 2021
10.4.8 Kuwait Drug Repositioning Consumption Volume from 2016 to 2021
10.4.9 Oman Drug Repositioning Consumption Volume from 2016 to 2021
Chapter 11 Africa Drug Repositioning Market Analysis
11.1 Africa Drug Repositioning Consumption and Value Analysis
11.1.1 Africa Drug Repositioning Market Under COVID-19
11.2 Africa Drug Repositioning Consumption Volume by Types
11.3 Africa Drug Repositioning Consumption Structure by Application
11.4 Africa Drug Repositioning Consumption by Top Countries
11.4.1 Nigeria Drug Repositioning Consumption Volume from 2016 to 2021
11.4.2 South Africa Drug Repositioning Consumption Volume from 2016 to 2021
11.4.3 Egypt Drug Repositioning Consumption Volume from 2016 to 2021
11.4.4 Algeria Drug Repositioning Consumption Volume from 2016 to 2021
11.4.5 Morocco Drug Repositioning Consumption Volume from 2016 to 2021
Chapter 12 Oceania Drug Repositioning Market Analysis
12.1 Oceania Drug Repositioning Consumption and Value Analysis
12.2 Oceania Drug Repositioning Consumption Volume by Types
12.3 Oceania Drug Repositioning Consumption Structure by Application
12.4 Oceania Drug Repositioning Consumption by Top Countries
12.4.1 Australia Drug Repositioning Consumption Volume from 2016 to 2021
12.4.2 New Zealand Drug Repositioning Consumption Volume from 2016 to 2021
Chapter 13 South America Drug Repositioning Market Analysis
13.1 South America Drug Repositioning Consumption and Value Analysis
13.1.1 South America Drug Repositioning Market Under COVID-19
13.2 South America Drug Repositioning Consumption Volume by Types
13.3 South America Drug Repositioning Consumption Structure by Application
13.4 South America Drug Repositioning Consumption Volume by Major Countries
13.4.1 Brazil Drug Repositioning Consumption Volume from 2016 to 2021
13.4.2 Argentina Drug Repositioning Consumption Volume from 2016 to 2021
13.4.3 Columbia Drug Repositioning Consumption Volume from 2016 to 2021
13.4.4 Chile Drug Repositioning Consumption Volume from 2016 to 2021
13.4.5 Venezuela Drug Repositioning Consumption Volume from 2016 to 2021
13.4.6 Peru Drug Repositioning Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Drug Repositioning Consumption Volume from 2016 to 2021
13.4.8 Ecuador Drug Repositioning Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Drug Repositioning Business
14.1 Novartis AG
14.1.1 Novartis AG Company Profile
14.1.2 Novartis AG Drug Repositioning Product Specification
14.1.3 Novartis AG Drug Repositioning Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Teva Pharmaceuticals
14.2.1 Teva Pharmaceuticals Company Profile
14.2.2 Teva Pharmaceuticals Drug Repositioning Product Specification
14.2.3 Teva Pharmaceuticals Drug Repositioning Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Johnson & Johnson
14.3.1 Johnson & Johnson Company Profile
14.3.2 Johnson & Johnson Drug Repositioning Product Specification
14.3.3 Johnson & Johnson Drug Repositioning Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Abbott Healthcare
14.4.1 Abbott Healthcare Company Profile
14.4.2 Abbott Healthcare Drug Repositioning Product Specification
14.4.3 Abbott Healthcare Drug Repositioning Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Mylan Inc.
14.5.1 Mylan Inc. Company Profile
14.5.2 Mylan Inc. Drug Repositioning Product Specification
14.5.3 Mylan Inc. Drug Repositioning Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Pfizer
14.6.1 Pfizer Company Profile
14.6.2 Pfizer Drug Repositioning Product Specification
14.6.3 Pfizer Drug Repositioning Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Sandoz
14.7.1 Sandoz Company Profile
14.7.2 Sandoz Drug Repositioning Product Specification
14.7.3 Sandoz Drug Repositioning Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Hoffmann-La Roche
14.8.1 Hoffmann-La Roche Company Profile
14.8.2 Hoffmann-La Roche Drug Repositioning Product Specification
14.8.3 Hoffmann-La Roche Drug Repositioning Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Drug Repositioning Market Forecast (2022-2027)
15.1 Global Drug Repositioning Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Drug Repositioning Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Drug Repositioning Value and Growth Rate Forecast (2022-2027)
15.2 Global Drug Repositioning Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Drug Repositioning Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Drug Repositioning Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Drug Repositioning Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Drug Repositioning Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Drug Repositioning Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Drug Repositioning Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Drug Repositioning Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Drug Repositioning Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Drug Repositioning Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Drug Repositioning Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Drug Repositioning Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Drug Repositioning Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Drug Repositioning Consumption Forecast by Type (2022-2027)
15.3.2 Global Drug Repositioning Revenue Forecast by Type (2022-2027)
15.3.3 Global Drug Repositioning Price Forecast by Type (2022-2027)
15.4 Global Drug Repositioning Consumption Volume Forecast by Application (2022-2027)
15.5 Drug Repositioning Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
